Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Luna Fit
HealthRX review
A LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injections — both molecules, transparent no-insurance pricing, and an accreditation signal that reassures when hormones are in play.
- Semaglutide
- $190/mo month-to-month ($99 first month, renews at $165) · $99/mo on a 12-month prepay ($1,188)
- Tirzepatide
- $239/mo month-to-month ($149 first month, renews at $214) · $179/mo on a 12-month prepay ($2,148)
- Coverage
- Not publicly listed
- Brand-name
- Yes
The Luna Fit scorecard
HealthRX scored on our six women's-health factors. See the methodology.
What we like
- LegitScript-certified (a meaningful third-party trust signal) with physician-supervised care, not a prescription-only handoff
- Both molecules plus a rare oral GLP-1 tablet — real optionality for the needle-averse and for insulin-resistant PCOS
- Transparent, no-insurance flat pricing — injectable GLP-1 around $189/mo, oral tablet around $239/mo, GLP+GIP around $349/mo
- Compounded from US pharmacies with an optional brand path (Ozempic) if you and your clinician want a name-brand route
The caveats
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- Some tiers are company-stated and the public site is thin, so a few figures can't be verified live
- Brand-name tiers are pass-through and expensive — brand Ozempic runs about $1,299/mo
- States served are not publicly listed, so nationwide access can't be confirmed
The bottom line
Best for: Women who want a LegitScript-certified, physician-supervised program with both molecules, an oral-tablet route as well as injections, and transparent flat pricing with no insurance to navigate. A LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injections — both molecules, transparent no-insurance pricing, and an accreditation signal that reassures when hormones are in play.
Ranked #6 of 71 providers we reviewed for women — see our #1 pick, CoreAge Rx, for comparison. Nationwide access is where HealthRX scores lowest, at 80/100. If that is your sticking point, start with what women pick instead of HealthRX.
Others in HealthRX's score range
The providers scoring closest to HealthRX on the same six factors. One of those comparisons is written out in full: the HealthRX–CoreAge Rx head-to-head, 8 points apart on the Luna Fit Score. Directly below HealthRX sits MadeMed at #7 with 84/100 — see the alternatives to MadeMed we rank for women if that is the band you are shopping in.
See all 71 providers we've reviewed for women — ranked on the same rubric, with scores and pricing side by side.
Pricing, states and verification reflect HealthRX's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on HealthRX's site. Not medical advice; see our disclosure.